Completed PHASE4 INTERVENTIONAL NCT00349258

The Use of GnRH Agonist Trigger in the Prevention of OHSS

A Prospective Randomized Study Comparing the Use of hCG or GnRH Agonist to Trigger Final Oocyte Maturation in High Responders Undergoing in-Vitro Fertilization Treatment

Sponsor: Organon

Conditions Ovarian Hyperstimulation Syndrome

Interventions Leuprolide acetate

Updated 4 times since 2017 Last updated: Jul 5, 2006 Started: Aug 31, 2004 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Ovarian Hyperstimulation Syndrome, this trial is completed. The trial is conducted by Organon and has accumulated 4 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organon
University of Connecticut

Data source: UConn Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farmington, United States